Nifty

:

24273.80

Sensex

:

80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Login

Nifty
Sensex

:
:

24273.80
80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

2260.65

06-Feb-2025

Open
High
Low
Previous Close

2000.00
2364.00
1992.00
1999.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2465345
53723.44
3148.00
1921.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

46,433.35
54.04
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

45,323.34
1.17%
24.41

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.27
1.38
1.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.69
6.69
3.59

PAT CAGR (%)

10 Years
5 Years
3 Years

2.16
44.64
15.71

P:E (Median)

8 Years
5 Years
3 Years

60.15
53.94
42.61

P:BV (Average)

8 Years
5 Years
3 Years

15.18
17.55
17.66

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.19
30.88
30.45

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 34.83 50.63 58.22 64.05
P/E Ratio 68.49 47.12 40.98 37.24
Revenue 3454 3739 4149 4455
EBITDA 909 1104 1255 1345
Net Income 590 858 986 1085
ROA 17.1 32.7 35.7
P/B Ratio 22.73 19.72 16.53 13.13
ROE 33.53 43.81 42.98 38.4
FCFF 644 833.87 1081.92 1158.29
FCFF Yield 1.66 2.16 2.8 2.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 946.36 804.98 17.56% 1,000.05 953.38 4.90% 811.00 738.02 9.89% 910.87 782.16 16.46%
Expenses 656.18 587.47 11.70% 681.10 666.80 2.14% 581.58 596.77 -2.55% 655.56 615.40 6.53%
EBITDA 290.18 217.51 33.41% 318.95 286.58 11.30% 229.42 141.25 62.42% 255.31 166.76 53.10%
EBIDTM 30.66% 27.02% 31.89% 30.06% 28.29% 19.14% 28.03% 21.32%
Other Income 35.06 28.34 23.71% 32.19 28.47 13.07% 35.85 36.80 -2.58% 29.87 27.97 6.79%
Interest 0.09 0.32 -71.88% 0.27 0.43 -37.21% 0.37 0.28 32.14% 0.77 0.65 18.46%
Depreciation 18.80 17.11 9.88% 16.86 18.11 -6.90% 16.41 16.36 0.31% 18.10 17.18 5.36%
PBT 306.35 65.11 370.51% 338.70 296.51 14.23% 248.49 178.71 39.05% 268.71 187.30 43.47%
Tax 77.77 19.62 296.38% 90.01 80.97 11.16% 66.84 48.13 38.87% 75.63 55.82 35.49%
PAT 228.58 45.49 402.48% 248.69 215.54 15.38% 181.65 130.58 39.11% 193.08 131.48 46.85%
PATM 24.15% 5.65% 24.87% 22.61% 22.40% 17.69% 21.20% 16.81%
EPS 13.49 2.69 401.49% 14.68 12.72 15.41% 10.72 7.71 39.04% 11.40 7.76 46.91%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 949.42 805.26 17.90% 1,010.77 956.99 5.62% 814.65 761.66 6.96% 929.80 787.45 18.08%
Expenses 657.50 587.20 11.97% 689.06 667.50 3.23% 584.11 617.78 -5.45% 672.54 617.71 8.88%
EBITDA 291.92 218.06 33.87% 321.71 289.49 11.13% 230.54 143.88 60.23% 257.26 169.74 51.56%
EBIDTM 30.75% 27.08% 31.83% 30.25% 28.30% 18.89% 27.67% 21.56%
Other Income 35.07 28.11 24.76% 34.54 28.21 22.44% 35.64 36.44 -2.20% 29.83 27.66 7.85%
Interest 0.09 0.32 -71.88% 0.27 0.43 -37.21% 0.37 0.28 32.14% 0.77 0.65 18.46%
Depreciation 18.80 17.11 9.88% 16.86 18.11 -6.90% 16.41 16.36 0.31% 18.10 17.18 5.36%
PBT 308.10 65.43 370.88% 343.81 299.16 14.93% 249.40 180.98 37.81% 270.62 189.97 42.45%
Tax 78.22 19.71 296.85% 91.31 81.65 11.83% 67.07 48.73 37.64% 76.14 56.54 34.67%
PAT 229.88 45.72 402.80% 252.50 217.51 16.09% 182.33 132.25 37.87% 194.48 133.43 45.75%
PATM 24.21% 5.68% 24.98% 22.73% 22.38% 17.36% 20.92% 16.94%
EPS 13.57 2.70 402.59% 14.90 12.84 16.04% 10.76 7.81 37.77% 11.48 7.88 45.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,668.28 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 Net Sales Growth 11.89% 5.94% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% Cost Of Goods Sold 1,369.99 1,288.43 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 Gross Profit 2,298.29 2,118.82 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 GP Margin 62.65% 62.19% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% Total Expenditure 2,574.42 2,506.60 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.87% 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.33% 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 % Of Sales - 3.33% 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% General & Admin Exp. - 190.48 189.33 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 % Of Sales - 5.59% 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.88 164.26 222.32 % Of Sales - 5.41% 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% Miscellaneous Exp. - 75.82 72.95 64.17 78.51 111.89 106.88 104.29 96.61 125.19 222.32 % Of Sales - 2.23% 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% EBITDA 1,093.86 900.65 799.42 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 EBITDA Margin 29.82% 26.43% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% Other Income 132.97 123.48 101.51 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 Interest 1.50 1.80 1.81 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation 70.17 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT 1,162.25 952.65 833.36 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 Tax 310.25 224.35 227.69 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 Tax Rate 26.69% 27.73% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% PAT 852.00 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 PAT before Minority Interest 852.00 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.23% 17.16% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% PAT Growth 62.88% -3.31% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% EPS 50.30 34.52 35.70 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,704.64 3,453.71 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 Net Sales Growth 11.88% 6.21% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% Cost Of Goods Sold 1,406.05 1,334.53 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 Gross Profit 2,298.59 2,119.18 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 GP Margin 62.05% 61.36% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% Total Expenditure 2,603.21 2,545.02 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.86% 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.08% 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 % Of Sales - 3.29% 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% General & Admin Exp. - 190.50 189.33 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 % Of Sales - 5.52% 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.91 164.47 222.31 % Of Sales - 5.33% 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% Miscellaneous Exp. - 68.13 68.62 58.09 75.74 112.58 107.20 105.12 98.67 127.99 222.31 % Of Sales - 1.97% 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% EBITDA 1,101.43 908.69 804.28 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 EBITDA Margin 29.73% 26.31% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% Other Income 135.08 122.59 100.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 Interest 1.50 1.80 1.81 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation 70.17 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT 1,171.93 959.80 837.37 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 Tax 312.74 226.23 228.76 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 Tax Rate 26.69% 27.72% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% PAT 859.19 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 PAT before Minority Interest 859.19 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.19% 17.08% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% PAT Growth 62.45% -2.91% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% EPS 50.72 34.83 35.87 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,784.09 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,623.69 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 Non-Current Liabilities 106.82 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 246.21 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 Current Liabilities 1,510.94 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 Trade Payables 613.24 418.56 555.45 447.99 354.19 402.96 502.53 275.92 323.09 305.89 Other Current Liabilities 205.60 184.47 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 Total Liabilities 3,401.85 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 Gross Block 663.27 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 Accumulated Depreciation 342.91 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 196.13 Non Current Assets 636.01 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 24.49 24.49 24.49 25.82 25.97 26.17 49.43 52.99 53.63 47.67 Long Term Loans & Adv. 275.12 351.98 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 Other Non Current Assets 1.22 1.08 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 Current Assets 2,765.84 2,466.72 3,670.60 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 514.29 437.70 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,061.20 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 Other Current Assets 155.07 155.40 79.55 218.22 107.54 1,578.61 1,585.33 332.19 121.90 197.99 Short Term Loans & Adv. 24.68 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 Net Current Assets 1,254.90 1,149.69 1,996.24 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 Total Assets 3,401.85 3,194.52 4,509.70 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,777.64 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,617.24 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 Non-Current Liabilities 107.72 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 247.46 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 Current Liabilities 1,524.95 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 Trade Payables 625.41 427.79 579.33 466.13 357.06 405.81 505.86 278.93 327.74 308.04 Other Current Liabilities 207.44 184.59 503.74 450.11 222.85 802.71 842.35 390.47 202.82 130.09 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 Total Liabilities 3,410.31 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 Gross Block 680.87 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 Accumulated Depreciation 360.52 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 240.26 Non Current Assets 611.89 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 0.00 0.00 0.00 1.35 1.49 1.69 1.84 5.40 6.04 0.06 Long Term Loans & Adv. 275.44 347.40 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 Other Non Current Assets 1.24 1.10 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 Current Assets 2,798.42 2,494.26 3,707.92 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 525.05 459.97 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,063.22 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 Other Current Assets 174.87 155.48 89.49 225.89 108.85 1,580.88 1,591.97 338.90 333.82 200.47 Short Term Loans & Adv. 24.68 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 Net Current Assets 1,273.47 1,167.89 2,009.49 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 Total Assets 3,410.31 3,193.03 4,520.02 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 578.94 487.94 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 PBT 952.65 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 Adjustment -46.14 -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 Changes in Working Capital 64.55 -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 Cash after chg. in Working capital 971.06 757.61 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.67 -262.86 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 14.97 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 333.11 989.73 -47.11 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 Cash from Financing Activity -561.50 -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 32.41 -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 Opening Cash & Equivalents 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 Closing Cash & Equivalent 62.15 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 582.02 484.23 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 PBT 959.80 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 Adjustment -45.13 -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 Changes in Working Capital 61.02 -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 Cash after chg. in Working capital 975.69 755.75 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -254.23 -264.71 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 8.71 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 326.85 992.39 -32.96 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 Cash from Financing Activity -561.50 -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 29.23 -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 Opening Cash & Equivalents 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 Closing Cash & Equivalent 64.17 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.85 103.58 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 ROA 17.73% 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% ROE 32.96% 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% ROCE 45.85% 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% Fixed Asset Turnover 5.76 5.77 5.93 3.04 3.21 6.48 8.22 11.35 10.32 11.16 Receivable days 20.23 20.54 21.73 18.45 12.47 15.60 20.03 18.12 14.65 10.40 Inventory Days 46.48 49.10 53.51 58.87 54.87 57.56 58.34 57.72 57.50 37.61 Payable days 146.15 142.20 141.33 117.18 57.46 72.90 65.55 50.91 53.40 43.13 Cash Conversion Cycle -79.44 -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 450.79 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.47 102.89 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 ROA 17.87% 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% ROE 33.43% 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% ROCE 46.49% 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% Fixed Asset Turnover 5.25 5.31 6.03 3.04 3.21 6.48 8.21 11.38 9.59 9.82 Receivable days 21.90 22.32 21.37 18.42 12.47 15.60 20.03 18.09 14.59 10.35 Inventory Days 52.05 55.82 54.91 60.14 54.88 57.56 58.36 57.89 57.97 38.01 Payable days 144.03 143.05 140.69 119.53 57.89 73.24 66.07 51.56 53.81 43.72 Cash Conversion Cycle -70.08 -64.91 -64.41 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 454.77 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26

Top Investors:

sbi nifty midcap 150 index fund

life insurance corporation of india - p & gs fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
14th Feb 2025, 15:27 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback